Melanoma risk guides management of patients with melanocytic nevi

May 1, 2001

Washington - Management of patients with melanocytic nevi maybe improved in the future by advances that allow identification of congenitalnevi that are obligate precursors for malignant melanoma and true risk markersfor melanoma in individuals with dysplastic nevi, Darrell S. Rigel, M.D.,said at the annual meeting of the American Academy of Dermatology.